,,ii  #aah? ,,congress  #b;d ,session   
,s4 #ddai  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,may #bc1 #bjbd,mr4    
,cornyn 7= himself1 ,mr4 ,oss(f1 ,ms4   
,s9ema1 & ,mr4 ,lank=d7 introduc$ !     
foll[+ bill2 :i* 0 read twice & ref]r$  
to ! ,committee on ,homel& ,security &  
,gov]nm5tal ,affairs  ,a ,,bill  ,to    
require ! ,sci5ce & ,te*nology          
,directorate 9 ! ,dep>tm5t ( ,homel&    
,security to develop great] capacity to 
detect1 id5tify1 & disrupt illicit      
sub/ances 9 v l[ conc5trations4  #a4    
,%ort titles ,?is ,act may be cit$ z !  
,detection ,equipm5t & ,te*nology       
,evaluation to ,c\nt] ! ,?reat (        
,f5tanyl & ,xylaz9e ,act ( #bjbd or !   
,,detect ,f5tanyl & ,xylaz9e ,act (     
#bjbd4  #b4 ,enhanc+ ! capacity to      
detect1 id5tify1 & disrupt drugs su* z  
f5tanyl & xylaz9e ,section #cjb ( !     
,homel& ,security ,act ( #bjjb 7#f      
,u4,s4,c4 #ahb7 is am5d$-- 7#a7 9       
p>agraph 7#ac71 by /rik+ & at ! end2    
7#b7 9 p>agraph 7#ad71 by /rik+ ! p]iod 

at ! end & ins]t+ 2 &2 &  7#c7 by add+  
at ! end ! foll[+3  7#ae7 c>ry+ out     
rese>*1 developm5t1 te/+1 evaluation1 & 
co/-b5efit analyses to improve ! safety1
 effectiv5ess1 & effici5cy ( equipm5t & 
ref]5ce libr>ies = use by ,f$]al1 ,/ate1
 local1 & ,tribal law en=cem5t ag5cies =
 ! accurate detection ( drugs or !      
disruption ( drug traffick+ = drugs su* 
z f5tanyl & xylaz9e1 includ+1 b n limit$
 to-- 7,a7 portable equipm5t t c detect 
& id5tify drugs ) m9imal or no h&l+ ( ! 
sample2  7,b7 equipm5t t c sep>ate      
complex mixtures conta9+ l[             
conc5trations ( drugs & high            
conc5trations ( cutt+ ag5ts into _!     
compon5t p>ts to enable signature       
extraction = field id5tification &      
detection2 &  7,c7 te*nologies t use    
ma*9e le>n+ or artificial intellig5ce 7z
 def9$ 9 section #ejjb ( ! ,national    
,artificial ,intellig5ce ,initiative    
,act ( #bjbj 7#ae ,u4,s4,c4 #idja77 &   
o!r te*niques to pr$ict :e!r ! sub/ances
 9 a sample are controll$ sub/ance      

analogues or o!r new psy*oactive        
sub/ances n yet includ$ 9 available     
ref]5ce libr>ies4  4  #c4 ,requirem5ts  
,9 c>ry+ out section #cjb7ae7 ( !       
,homel& ,security ,act ( #bjjb1 z add$  
by section #b1 ! ,"u ,secret>y = ,sci5ce
 & ,te*nology %all-- 7#a7 foll[ !       
recomm5dations1 guidel9es1 & be/        
practices describ$ 9 ! ,artificial      
,intellig5ce ,risk ,managem5t ,framework
 7,,ni/ ,,ai #ajj-a7 or any successor   
docum5t publi%$ by ! ,national ,in/itute
 ( ,/&>ds & ,te*nology2 &  7#b7 e/abli% 
! ,directorate ( ,sci5ce & ,te*nology's 
rese>*1 developm5t1 te/+1 evaluation1 & 
co/-b5efit analysis priorities "u su*   
section #cjb7ae7 bas$ on ! late/        
available in=mation1 includ+ ! late/    
,/ate & ,t]ritory ,report on ,endur+ &  
,em]g+ ,?reats publi%$ by ! ,drug       
,en=cem5t ,adm9i/ration or any successor
 docum5t4